Impact of hemoglobin (Hb) on outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non-small cell lung cancer (NSCLC) in JBR.10.

被引：0
|
作者：
Gauthier, I
Ding, K
Winton, T
Shepherd, F
Livingston, R
Johnson, DH
Rigas, JR
Whitehead, M
Graham, B
Seymour, L
机构：
[1] Natl Canc Inst, Kingston, ON, Canada
[2] SW Oncol Grp, Seattle, WA USA
[3] Eastern Cooperat Oncol Grp, Nashville, TN USA
[4] Canc & Leukemia Grp B, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：670S / 670S
页数：1
相关论文
共 50 条
  • [21] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Makoto Sonobe
    Ken-ichi Okubo
    Satoshi Teramukai
    Kazuhiro Yanagihara
    Masaaki Sato
    Toshihiko Sato
    Fengshi Chen
    Kiyoshi Sato
    Takuji Fujinaga
    Tsuyoshi Shoji
    Mitsugu Omasa
    Hiroaki Sakai
    Ryo Miyahara
    Toru Bando
    Hiroshi Date
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1199 - 1206
  • [22] Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer
    Sonobe, Makoto
    Okubo, Ken-ichi
    Teramukai, Satoshi
    Yanagihara, Kazuhiro
    Sato, Masaaki
    Sato, Toshihiko
    Chen, Fengshi
    Sato, Kiyoshi
    Fujinaga, Takuji
    Shoji, Tsuyoshi
    Omasa, Mitsugu
    Sakai, Hiroaki
    Miyahara, Ryo
    Bando, Toru
    Date, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1199 - 1206
  • [23] Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC)
    Vincent, M. D.
    Butts, C.
    Seymour, L.
    Ding, K.
    Graham, B.
    Twumasi-Ankrah, P.
    Gandara, D.
    Schiller, J.
    Green, M.
    Shepherd, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Feasibility study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage H-IHA non-small cell lung cancer
    Yoshimura, N.
    Kudoh, S.
    Mitsuoka, S.
    Kimura, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)
    Rosell, R
    de Lena, M
    Carpagnano, F
    Ramlau, R
    Gonzalez-Larriba, J
    Grodzki, T
    Le Groumellec, A
    Aubert, D
    Gasmi, J
    Douillard, J
    LUNG CANCER, 2005, 49 : S3 - S4
  • [26] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [27] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [28] Adjuvant chemotherapy for resected non-small cell lung cancer
    Booth, Christopher M.
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 180 - 187
  • [29] Adjuvant Chemotherapy for Resected Non-Small Cell Lung Cancer
    Wakelee, Heather
    Chhatwani, Laveena
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 198 - 203
  • [30] Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial
    Bennouna, Jaafar
    Senellart, Helene
    Hiret, Sandrine
    Vaissiere, Nathalie
    Douillard, Jean-Yves
    LUNG CANCER, 2011, 74 (01) : 30 - 34
12345